Pine Brook, NJ, United States of America

Yu-Ching Eugene Pan


Average Co-Inventor Count = 6.7

ph-index = 4

Forward Citations = 76(Granted Patents)


Company Filing History:


Years Active: 1995-2012

Loading Chart...
4 patents (USPTO):Explore Patents

Title: **Innovative Contributions of Yu-Ching Eugene Pan in Cytokine Research**

Introduction

Yu-Ching Eugene Pan, a prominent inventor based in Pine Brook, NJ, has made significant strides in the field of immunology with his pioneering research. Holding four patents, his contributions primarily focus on cytokine proteins that play vital roles in immune response modulation.

Latest Patents

One of Yu-Ching Eugene Pan's latest patents revolves around the purification and characterization of a novel cytokine known as IL-12 or Cytotoxic Lymphocyte Maturation Factor (CLMF). This groundbreaking invention describes how CLMF, produced by human NC-37 B lymphoblastoid cells, works synergistically with low concentrations of IL-2 to enhance the cytolytic activity of Lymphokine Activated Killer (LAK) cells. Furthermore, CLMF is noted for its capability to promote T-cell growth. The patent also claims the cloned gene for CLMF, along with its recombination in a suitable vector, the cells transformed with said vector, the recombinant protein yielded by these transformed cells, and the antibodies specific to CLMF.

Career Highlights

Yu-Ching Eugene Pan is affiliated with Hoffmann-La Roche Inc., a respected pharmaceutical company dedicated to innovative healthcare solutions. Her work here has been instrumental in advancing our understanding of cytokines and their therapeutic potential.

Collaborations

Throughout her career, Yu-Ching has collaborated with several influential figures in the field, including Maurice Kent Gately and Ulrich Andreas Gubler. These partnerships have fostered a collaborative environment that enhances the impact of their scientific discoveries.

Conclusion

In summary, Yu-Ching Eugene Pan stands out as a dedicated inventor whose work in cytokine research is paving the way for innovative therapeutic strategies. Her contributions not only highlight her expertise but also underscore the importance of collaboration in scientific advancements. Through her patents, she continues to influence the future of immunology and cancer therapy.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…